No black box warning on record for Amlodipine Besylate

As of the latest FDA labeling reviewed, Amlodipine Besylate (AMLODIPINE BESYLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Amlodipine Besylate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely. ( 5.1 ) Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of amlodipine, particularly in patients with severe obstructive coronary artery disease. ( 5.2 ) Titrate slowly in patients with severe

No black box warning on record for Amlodipine Besylate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely. ( 5.1 ) Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of amlodipine, particularly in patients with severe obstructive coronary artery disease. ( 5.2 ) Titrate slowly in patients with severe

Amlodipine Besylate Black Box Warning

No black box warning on record for Amlodipine Besylate

Other warnings & precautions

Amlodipine Besylate Black Box Warning

No black box warning on record for Amlodipine Besylate

Other warnings & precautions